Tadanori Tomita1, Jerome M Volk2, Wenjun Shen2,3, Tatiana Pundy2. 1. Division of Pediatric Neurosurgery, Ann and Robert Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, 225 E. Chicago Avenue, Box 28, Chicago, IL, 60611-2605, USA. ttomita@luriechildrens.org. 2. Division of Pediatric Neurosurgery, Ann and Robert Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, 225 E. Chicago Avenue, Box 28, Chicago, IL, 60611-2605, USA. 3. Department of Pediatric Neurosurgery, Children's Hospital of Fudan University, Shanghai, China.
Abstract
OBJECT: Glioneuronal tumors are common neoplasms among the cerebral hemisphere during childhood. They consist of several histological types, of which gangliogliomas (GGs) and dysembryoplastic neuroepithelial tumors (DNTs) are most common and often present with seizures. A great majority of glioneuronal tumors are benign. However, there are conflict reports regarding postoperative tumor recurrence rates and seizure control. The authors analyzed and compared these tumors for their locations and histology and the tumor and seizure control following resection. METHODS: The authors conducted a retrospective analysis of patients with pediatric glioneuronal tumors in the cerebral hemisphere. All histology reports and neuroimaging are reviewed. Seizure group and non-seizure group were compared with their tumor types and locations. The extent of tumor resections were divided into gross total resection (GTR) and subtotal resection (STR). Postoperative tumor recurrence-free survival (RFS) and seizure-free survival for patients who had the initial surgery done at our institution were calculated using Kaplan-Meier method. RESULTS: There were 90 glioneuronal tumors including 58 GGs, 22 DNTs, 3 papillary glioneuronal tumor, 3 desmoplastic infantile gangliogliomas, 3 anaplastic GGs, and 1 central neurocytoma. Seventy-one patients (seizure group) presented with seizures. The temporal lobe is the most common location, 50 % in this series. GTR was attained in 79 patients and STR in 11. All of the patients with GTR had lesionectomy, and only six of them had extended corticectomy or partial lobectomy. Postoperative seizure outcome showed that 64 (90 %) of seizure group had Engel's class I, but five patients subsequently developed recurrent seizures. Patients with DNTs had a higher seizure recurrence rate. Tumor RFS was 87 % at 5 years and 75.5 % at 10 years. There are no significant difference in tumor recurrences between GGs and DNTs (p = 0.876). Comparison between GRT (67) and STR (9) showed that in spite of the better 5-year tumor RFSs among GRT group (94 %) than STR group (66 %), the 10-year RFSs showed no significant difference between GRT and STR groups (p = 0.719). Recurrent seizures are often related to recurrent tumor. CONCLUSION: Lesionectomy alone often provides a high-rate seizure freedom. GGs and DNTs are benign tumor, but recurrences of GGs and DNTs are not uncommon. They may show late recurrences in spite of GTR. These patients need longer follow-up for 10 years. Recurrent seizures are often related to a tumor recurrence.
OBJECT: Glioneuronal tumors are common neoplasms among the cerebral hemisphere during childhood. They consist of several histological types, of which gangliogliomas (GGs) and dysembryoplastic neuroepithelial tumors (DNTs) are most common and often present with seizures. A great majority of glioneuronal tumors are benign. However, there are conflict reports regarding postoperative tumor recurrence rates and seizure control. The authors analyzed and compared these tumors for their locations and histology and the tumor and seizure control following resection. METHODS: The authors conducted a retrospective analysis of patients with pediatric glioneuronal tumors in the cerebral hemisphere. All histology reports and neuroimaging are reviewed. Seizure group and non-seizure group were compared with their tumor types and locations. The extent of tumor resections were divided into gross total resection (GTR) and subtotal resection (STR). Postoperative tumor recurrence-free survival (RFS) and seizure-free survival for patients who had the initial surgery done at our institution were calculated using Kaplan-Meier method. RESULTS: There were 90 glioneuronal tumors including 58 GGs, 22 DNTs, 3 papillary glioneuronal tumor, 3 desmoplastic infantile gangliogliomas, 3 anaplastic GGs, and 1 central neurocytoma. Seventy-one patients (seizure group) presented with seizures. The temporal lobe is the most common location, 50 % in this series. GTR was attained in 79 patients and STR in 11. All of the patients with GTR had lesionectomy, and only six of them had extended corticectomy or partial lobectomy. Postoperative seizure outcome showed that 64 (90 %) of seizure group had Engel's class I, but five patients subsequently developed recurrent seizures. Patients with DNTs had a higher seizure recurrence rate. Tumor RFS was 87 % at 5 years and 75.5 % at 10 years. There are no significant difference in tumor recurrences between GGs and DNTs (p = 0.876). Comparison between GRT (67) and STR (9) showed that in spite of the better 5-year tumor RFSs among GRT group (94 %) than STR group (66 %), the 10-year RFSs showed no significant difference between GRT and STR groups (p = 0.719). Recurrent seizures are often related to recurrent tumor. CONCLUSION: Lesionectomy alone often provides a high-rate seizure freedom. GGs and DNTs are benign tumor, but recurrences of GGs and DNTs are not uncommon. They may show late recurrences in spite of GTR. These patients need longer follow-up for 10 years. Recurrent seizures are often related to a tumor recurrence.
Authors: Ingmar Blümcke; Maria Thom; Eleonora Aronica; Dawna D Armstrong; Harry V Vinters; Andre Palmini; Thomas S Jacques; Giuliano Avanzini; A James Barkovich; Giorgio Battaglia; Albert Becker; Carlos Cepeda; Fernando Cendes; Nadia Colombo; Peter Crino; J Helen Cross; Olivier Delalande; François Dubeau; John Duncan; Renzo Guerrini; Philippe Kahane; Gary Mathern; Imad Najm; Ciğdem Ozkara; Charles Raybaud; Alfonso Represa; Steven N Roper; Noriko Salamon; Andreas Schulze-Bonhage; Laura Tassi; Annamaria Vezzani; Roberto Spreafico Journal: Epilepsia Date: 2010-11-10 Impact factor: 5.864
Authors: Hideki Ogiwara; Douglas R Nordli; Arthur J DiPatri; Tord D Alden; Robin M Bowman; Tadanori Tomita Journal: J Neurosurg Pediatr Date: 2010-03 Impact factor: 2.375
Authors: Michael Majores; Marec von Lehe; Jana Fassunke; Johannes Schramm; Albert J Becker; Matthias Simon Journal: Cancer Date: 2008-12-15 Impact factor: 6.860
Authors: T Komori; B W Scheithauer; D C Anthony; M K Rosenblum; R E McLendon; R M Scott; H Okazaki; M Kobayashi Journal: Am J Surg Pathol Date: 1998-10 Impact factor: 6.394
Authors: Wilson Z Ray; Spiros L Blackburn; Sandro Casavilca-Zambrano; Carlos Barrionuevo; Jose E Orrego; Hugo Heinicke; Joshua L Dowling; Arie Perry Journal: J Neurooncol Date: 2009-03-08 Impact factor: 4.130
Authors: Dario J Englot; Jonathan D Breshears; Peter P Sun; Edward F Chang; Kurtis I Auguste Journal: J Neurosurg Pediatr Date: 2013-06-14 Impact factor: 2.375
Authors: Shelly Wang; Matthew Z Sun; I Joshua Abecassis; Alexander G Weil; George M Ibrahim; Aria Fallah; Chibawanye Ene; Sarah E S Leary; Bonnie L Cole; Christina M Lockwood; James M Olson; J Russell Geyer; Richard G Ellenbogen; Jeffrey G Ojemann; Anthony C Wang Journal: J Neurooncol Date: 2021-10-06 Impact factor: 4.506
Authors: David Pitskhelauri; Elina Kudieva; Maria Kamenetskaya; Antonina Kozlova; Pavel Vlasov; Baiyr Dombaanai; Natalia Eliseeva; Lyudmila Shishkina; Alexander Sanikidze; Evgeniy Shults; Dmitriy Moshev; Igor Pronin; Armen Melikyan Journal: Surg Neurol Int Date: 2021-07-27